Vivanza Biosciences Ltd.BSE: VIVANZA

Board Meeting Outcome for The Board Meeting Held On 11Th November, 2025

· Issued by Vivanza Biosciences Ltd. via BSE India

Pursuant to Regulations 30 and 33 of the SEBI (LODR) Regulations, 2015, we wish to inform that the Board of Directors, at its meeting held on Tuesday, 11th November, 2025, has inter alia considered and approved: (1) Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2025, along with the Limited Review Report; (2) Appointment of CS Chaitra Arora (M. No. A78376) as Company Secretary & Compliance Officer and noted the resignation of CS Siddhi Shah (M. No. A44885); (3) Alteration of the Main Object Clause of the Memorandum of Association to include manufacturing and trading of plastic and packaging materials, subject to shareholders' approval via Postal Ballot; (4) Approval of Postal Ballot Notice, Calendar of Events, cut-off date of 7th November, 2025, and appointment of Mr. Chintan K. Patel, PCS, as Scrutinizer.

View Attachment

View original source (BSE India)Vivanza Biosciences Ltd. on 6ix

Earlier from Vivanza Biosciences

Later from Vivanza Biosciences

All Vivanza Biosciences news releases